Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
NewsNation host Chris Cuomo expressed remorse for multiple aspects of his past news coverage during a Tuesday episode of “The...
The exchange said it has added support for outcome-based trading in a move to compete with prediction markets....
Last night, the music industry got together to say "F ICE," make fun of Trump and conservatives, and worship themselves....
